Contact
searchSearch
HMP Global

HIV/AIDS Topic Center

Poll
Treatment Timing for HIV Antiretroviral Therapy
12/09/2024
Do you believe that immediate initiation of antiretroviral therapy (ART) following an HIV diagnosis, as opposed to delaying treatment, significantly benefits individuals and communities?
Do you believe that immediate initiation of antiretroviral therapy (ART) following an HIV diagnosis, as opposed to delaying treatment, significantly benefits individuals and communities?
Do you believe that immediate...
12/09/2024
First Report Managed Care
Sponsored by ViiV Healthcare
Patient's Access Story With CABENUVA (cabotegravir; rilpivirine)
12/04/2024
In this video, Ida shares her experience of accessing CABENUVA.
In this video, Ida shares her experience of accessing CABENUVA.
In this video, Ida shares her...
12/04/2024
First Report Managed Care
Ed
Podcasts
Improving Adherence With Long-Acting Antiretroviral Therapy for HIV
11/15/2024
Edmund J. Pezalla, MD
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion...
11/15/2024
First Report Managed Care
Research Review
Long-Acting Antiretroviral Therapy Linked to Better Adherence and Persistence in HIV Treatment
10/14/2024
Hannah Musick
Research presented at AMCP Nexus 2024 suggests that switching to long-acting antiretroviral therapy (ART) may significantly improve adherence and persistence in people with HIV (PWH) compared to staying on traditional oral ART, offering a...
Research presented at AMCP Nexus 2024 suggests that switching to long-acting antiretroviral therapy (ART) may significantly improve adherence and persistence in people with HIV (PWH) compared to staying on traditional oral ART, offering a...
Research presented at AMCP Nexus...
10/14/2024
First Report Managed Care
News
Addressing Stigma is Essential for Increasing PrEP Uptake and Adherence in HIV Prevention Efforts
09/20/2024
Lisa Kuhns, PhD, MD
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated...
09/20/2024
First Report Managed Care
News
CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide
09/16/2024
Lisa Kuhns, PhD, MD
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control...
09/16/2024
First Report Managed Care
News
Study Finds Low Vaccination Rates Among Pregnant Women With HIV
08/23/2024
Lisa Kuhns, PhD, MD
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for...
08/23/2024
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Machine Learning Approach Identifies HIV-1 Broadly Neutralizing Antibodies
07/10/2024
Jolynn Tumolo
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been...
07/10/2024
First Report Managed Care
News
Johnson & Johnson Expands Use of Prezcobix for Pediatric Patients in the US
06/21/2024
Hannah Musick
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand...
06/21/2024
First Report Managed Care
Interactive Features
Poll Quiz

Related Content

FRMC Volume 22, Issue 1

Current Issue

March 2025
Volume 22
Issue 1
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use